Arnold L. Silva

Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease

Stuart M. Sprague, Arnold L. Silva, Fahd Al-Saghir et al. · American Journal of Nephrology · 2014 · 59 citations · Full text

Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

Glenn M. Chertow, Gerald B. Appel, Sharon Andreoli et al. · American Journal of Nephrology · 2021 · 47 citations · Full text

Effects of Bardoxolone Methyl in Alport Syndrome

Bradley A. Warady, Pablo E. Pérgola, Rajiv Agarwal et al. · Clinical Journal of the American Society of Nephrology · 2022 · 42 citations · Full text

Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM)

Geoffrey A. Block, Anthony J. Bleyer, Arnold L. Silva et al. · Kidney360 · 2021 · 35 citations · Full text

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease

Glenn M. Chertow, Gerald B. Appel, Geoffrey A. Block et al. · Journal of Diabetes and its Complications · 2018 · 18 citations · Full text